Michael S. Conte, MD
@MichaelSConteMD
Followers
1K
Following
46
Media
7
Statuses
78
Vascular surgeon and career surgeon-scientist. EJ Wylie Chair UCSF Vascular and Endovascular Surgery
Hillsborough, CA
Joined January 2019
Another great meeting with our gracious hosts Professors De Luccia and Puech at USP. I learn something new from them every time! International collaboration @UCSFvascular
2
2
52
Day 1 of the 5th annual joint UCSF-USP symposium in Sao Paolo!
1
4
33
The 1% egregious actors are tip of the iceberg. The echo chamber ecosystem of KOLs, pseudo-societies and mass marketing meetings is a machine to promote overuse and misuse on a daily basis
5
10
69
Meanwhile there is inadequate payment and this lack of availability for exercise, and many cannot afford good diabetic footwear. Broken system driven by commercial interests
1
2
15
Shameful and hopefully too powerful to ignore. Time for regulators and payors to act but we should be taking the lead in defining appropriate care
The onslaught of stories about #overtreatment of #claudication continues. Powerful @nytimes article on the cover today . . . And it really hits home. When will it stop??? #WeCanFoBetter #Appropriateness #PADEd @VascularSVS @JudithLin4
https://t.co/J2DDYTphfS
2
8
53
Proud to be one of the first institutions designated by the new ACS-SVS Vascular Verification Program
vascularspecialistonline.com
UCSF is among the first four hospitals in the U.S. to be verified as part of the ACS Vascular Verification Program
5
14
83
Sharing ideas and making friendships with a United goal to improve global vascular health❤️@UCSFvascular @UnifeCulture
UCSF-Unife Shared Training in Vascular Surgery: a beautiful meeting for Residents at the Educational Center of the Sant’Anna University Hospital #Ferrara @UCSFvascular @UnifeCulture @UniFerrara @SantAnnaNotizie @MichaelSConteMD
2
2
27
https://t.co/Df5B9M6YN1. Please keep in mind when trying to interpret single arm data eg from the DVA studies it’s very challenging no control group “no option” CLTI is quite broad eg AFS 60%@ 1 Year
pubmed.ncbi.nlm.nih.gov
Conservative treatment for patients with CLTI may be considered and does not always result in loss of limb or patient demise. The results of this review can be used to inform patients with CLTI about...
1
1
26
Well done!
Thank you to the Frank J Veith International Society for awarding us 1st prize for our work on a drug-eluting bioresorbable scaffold system for the femoropopliteal artery! #Efemoral @VEITHsymposium
0
0
23
Shown at the AHA presentation but not in the NEJM article. Not parallel, not close. Is what it is.
10
27
207
Vein bypass associated with <half total major reinterventions over time and no diff in MACE- clearly more effective than Endo by ITT
BEST-CLI shows bypass to be superior to endovascular revasc in pts with critical limb ischemia and a saphenous vein available as conduit with respect to primary outcome: MALE and all cause mortality! Also less amputations and reinterventions with bypass! #AHA2022
1
11
89
We are out in the world of evidence 🎉Enjoy the science, cardiovascular peeps!!!! #AHA2022
nejm.org
Patients with chronic limb-threatening ischemia (CLTI) require revascularization to improve limb perfusion and thereby limit the risk of amputation. It is uncertain whether an initial strategy of e...
9
141
309
BEST CLI landmark trial presented today at AHA by Drs Alik Farber and Matt Menard establishes evidence based care for CLTI
4
24
171
Great #WVS2021 in Jackson Hole! Outstanding science and great camaraderie. Congrats to new President @rowe_vincent and Pres Elect @weizhou74370988. Go Western Vascular! @westvascular
1
7
64